Neuren Pharmaceuticals Ltd. (NURPF)
12.91
0.00 (0.00%)
USD |
OTCM |
Jan 16, 16:00
Neuren Pharmaceuticals Market Cap: 1.630B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alterity Therapeutics Ltd. | 62.53M |
| Kazia Therapeutics Ltd. | 81.17M |
| Immutep Ltd. | 427.94M |
| Propanc Biopharma, Inc. | 4.190M |
| Mesoblast Ltd. | 2.233B |
Market Cap Related Metrics
| PS Ratio | 11.74 |
| PEG Ratio | 0.1061 |
| Price to Free Cash Flow | 19.17 |
| Price | 12.91 |
| Earnings Yield | 5.82% |
| PEGY Ratio | 0.1061 |
| Operating PE Ratio | 13.94 |
| Normalized PE Ratio | 17.11 |